SAN FRANCISCO--(BUSINESS WIRE)--Ossium Health, a clinical-stage bioengineering company with a first-of-its-kind bone marrow banking platform for processing and deploying hematopoietic stem cells ...

SAN FRANCISCO--(BUSINESS WIRE)--Ossium Health, a bioengineering company leveraging stem cell science to develop treatments for diseases of the blood and immune systems, has been named as a winner ...

Ossium Health is a bioengineering company that leverages its proprietary organ donor bone marrow banking platform to develop stem cell therapies for patients with life-threatening blood and immune ...

To help increase the chances of these patients getting life-saving treatment, the bioengineering company Ossium Health has created a program that offers deep-frozen bone marrow from deceased organ ...

Ossium Health, a clinical-stage bioengineering company with a first-of-its-kind bone marrow bank for processing and deploying stem cell-based therapies, today announced that it will be hosting a ...

Humacyte, a bioengineering company, went public through a SPAC merger in 2015, with a market value of $1.1 billion. The company has received FDA's RMAT designation for three indications ...

SAN FRANCISCO, July 30, 2024--(BUSINESS WIRE)--Ossium Health, a bioengineering company that entered the orthobiologics field in 2023, announced the first surgery using its next-generation viable ...

More than 100 employees from Ginkgo Bioworks, a Boston-based bioengineering company, are facing layoffs between August and December, according to a state database. In total, 158 employees in the ...

According to the U.K.'s Daily Star, the Argentina-based bioengineering company Kheiron Biotech announced that the first five genetically modified "super horses" have arrived and now reside in ...